{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:32:52Z","timestamp":1792787572555,"version":"4.5.0"},"reference-count":67,"publisher":"American Association for Cancer Research (AACR)","issue":"10","funder":[{"name":"Canc\u00e9ropole GSO","award":["2014-E07"],"award-info":[{"award-number":["2014-E07"]}]},{"name":"Programme Hospitalo-Universitaire en Canc\u00e9rologie","award":["ANR11-PHUC0001"],"award-info":[{"award-number":["ANR11-PHUC0001"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Relapses driven by chemoresistant leukemic cell populations are the main cause of mortality for patients with acute myeloid leukemia (AML). Here, we show that the ectonucleotidase CD39 (ENTPD1) is upregulated in cytarabine-resistant leukemic cells from both AML cell lines and patient samples in vivo and in vitro. CD39 cell-surface expression and activity is increased in patients with AML upon chemotherapy compared with diagnosis, and enrichment in CD39-expressing blasts is a marker of adverse prognosis in the clinics. High CD39 activity promotes cytarabine resistance by enhancing mitochondrial activity and biogenesis through activation of a cAMP-mediated adaptive mitochondrial stress response. Finally, genetic and pharmacologic inhibition of CD39 ecto-ATPase activity blocks the mitochondrial reprogramming triggered by cytarabine treatment and markedly enhances its cytotoxicity in AML cells in vitro and in vivo. Together, these results reveal CD39 as a new residual disease marker and a promising therapeutic target to improve chemotherapy response in AML.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Extracellular ATP and CD39\u2013P2RY13\u2013cAMP\u2013OxPHOS axis are key regulators of cytarabine resistance, offering a new promising therapeutic strategy in AML.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 1426<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-19-1008","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T14:15:14Z","timestamp":1594217714000},"page":"1544-1565","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia"],"prefix":"10.1158","volume":"10","author":[{"given":"Nesrine","family":"Aroua","sequence":"first","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Boet","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Ghisi","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Nicolau-Travers","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."},{"name":"3Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Saland","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Gwilliam","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"de Toni","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1686-8512","authenticated-orcid":false,"given":"Mohsen","family":"Hosseini","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Luc","family":"Mouchel","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."},{"name":"3Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4390-8073","authenticated-orcid":false,"given":"Thomas","family":"Farge","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudie","family":"Bosc","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Stuani","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Sabatier","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fetta","family":"Mazed","sequence":"additional","affiliation":[{"name":"4Institut Cochin, D\u00e9partement D\u00e9veloppement, Reproduction, Cancer, UMR8104-CNRS, U1016-INSERM, Paris."},{"name":"5Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Larrue","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Jarrou","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gandarillas","sequence":"additional","affiliation":[{"name":"6Centre R\u00e9gional d'Exploration Fonctionnelle et Ressources Exp\u00e9rimentales, Service d'Exp\u00e9rimentation Animale, UMS006, Inserm, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bardotti","sequence":"additional","affiliation":[{"name":"6Centre R\u00e9gional d'Exploration Fonctionnelle et Ressources Exp\u00e9rimentales, Service d'Exp\u00e9rimentation Animale, UMS006, Inserm, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Picard","sequence":"additional","affiliation":[{"name":"2University of Toulouse, Toulouse, France."},{"name":"7Intensive Care Unit, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Syrykh","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."},{"name":"8Service d'Anatomopathologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Laurent","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."},{"name":"8Service d'Anatomopathologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Gotan\u00e8gre","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4814-6722","authenticated-orcid":false,"given":"Nathalie","family":"Bonnefoy","sequence":"additional","affiliation":[{"name":"9Institut de Recherche en Canc\u00e9rologie de Montpellier, U1194, Inserm, Universit\u00e9 de Montpellier, Institut r\u00e9gional du Cancer de Montpellier, Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-8655","authenticated-orcid":false,"given":"Floriant","family":"Bellvert","sequence":"additional","affiliation":[{"name":"10TBI, Universit\u00e9 de Toulouse, CNRS, INRA, INSA, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Portais","sequence":"additional","affiliation":[{"name":"10TBI, Universit\u00e9 de Toulouse, CNRS, INRA, INSA, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7685-7241","authenticated-orcid":false,"given":"Nathalie","family":"Nicot","sequence":"additional","affiliation":[{"name":"11LuxGene, Quantitative Biology Unit, Luxembourg Institute of Health, Luxembourg, Luxembourg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Azuaje","sequence":"additional","affiliation":[{"name":"12Computational Biomedicine Research Group, Quantitative Biology Unit, Luxembourg Institute of Health, Luxembourg, Luxembourg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Kaoma","sequence":"additional","affiliation":[{"name":"12Computational Biomedicine Research Group, Quantitative Biology Unit, Luxembourg Institute of Health, Luxembourg, Luxembourg."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7551-356X","authenticated-orcid":false,"given":"Carine","family":"Joffre","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0167-5996","authenticated-orcid":false,"given":"J\u00e9rome","family":"Tamburini","sequence":"additional","affiliation":[{"name":"4Institut Cochin, D\u00e9partement D\u00e9veloppement, Reproduction, Cancer, UMR8104-CNRS, U1016-INSERM, Paris."},{"name":"5Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"R\u00e9cher","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."},{"name":"3Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vergez","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."},{"name":"3Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-2032","authenticated-orcid":false,"given":"Jean-Emmanuel","family":"Sarry","sequence":"additional","affiliation":[{"name":"1Centre de Recherches en Canc\u00e9rologie de Toulouse, UMR1037 Inserm\/Universit\u00e9 Toulouse III-Paul Sabatier, ERL5294 CNRS, Equipe Labellis\u00e9e LIGUE 2018, Toulouse, France."},{"name":"2University of Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"2022060701065178000_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/blood-2005-01-0178","article-title":"Drug therapy for acute myeloid leukemia","volume":"106","author":"Tallman","year":"2005","journal-title":"Blood"},{"key":"2022060701065178000_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","article-title":"Therapeutic advances in acute myeloid leukemia","volume":"29","author":"Burnett","year":"2011","journal-title":"J Clin Oncol"},{"key":"2022060701065178000_bib3","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2011.047894","article-title":"High levels of CD34+CD38low\/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study","volume":"96","author":"Vergez","year":"2011","journal-title":"Haematologica"},{"key":"2022060701065178000_bib4","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-05-0468","article-title":"High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival","volume":"11","author":"van Rhenen","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022060701065178000_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2022060701065178000_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"key":"2022060701065178000_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cmet.2017.10.013","article-title":"Resistance is futile: targeting mitochondrial energetics and metabolism to overcome drug resistance in cancer treatment","volume":"26","author":"Bosc","year":"2017","journal-title":"Cell Metab"},{"key":"2022060701065178000_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","article-title":"PGC1\u03b1 expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress","volume":"23","author":"Vazquez","year":"2013","journal-title":"Cancer Cell"},{"key":"2022060701065178000_bib9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat Med"},{"key":"2022060701065178000_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab"},{"key":"2022060701065178000_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.leukres.2017.09.021","article-title":"Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia","volume":"62","author":"Henkenius","year":"2017","journal-title":"Leuk Res"},{"key":"2022060701065178000_bib12","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.V97.7.2121","article-title":"Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination","volume":"97","author":"Stucki","year":"2001","journal-title":"Blood"},{"key":"2022060701065178000_bib13","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1182\/blood-2014-10-551507","article-title":"How I treat hyperleukocytosis in acute myeloid leukemia","volume":"125","author":"R\u00f6llig","year":"2015","journal-title":"Blood"},{"key":"2022060701065178000_bib14","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V70.4.1218.1218","article-title":"Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors","volume":"70","author":"Griffin","year":"1987","journal-title":"Blood"},{"key":"2022060701065178000_bib15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3324\/haematol.2017.184267","article-title":"Dexamethasone in hyperleukocytic acute myeloid leukemia","volume":"103","author":"Bertoli","year":"2018","journal-title":"Haematologica"},{"key":"2022060701065178000_bib16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3389\/fimmu.2017.01526","article-title":"Multifaceted effects of extracellular adenosine triphosphate and adenosine in the tumor-host interaction and therapeutic perspectives","volume":"8","author":"de Andrade Mello","year":"2017","journal-title":"Front Immunol"},{"key":"2022060701065178000_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.it.2012.02.009","article-title":"CD73: a potent suppressor of antitumor immune responses","volume":"33","author":"Beavis","year":"2012","journal-title":"Trends Immunol"},{"key":"2022060701065178000_bib18","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/onc.2012.269","article-title":"ENTPD1\/CD39 is a promising therapeutic target in oncology","volume":"32","author":"Bastid","year":"2013","journal-title":"Oncogene"},{"key":"2022060701065178000_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2022060701065178000_bib20","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.celrep.2019.04.091","article-title":"Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Rep"},{"key":"2022060701065178000_bib21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjh.12774","article-title":"Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis","volume":"165","author":"Dulphy","year":"2014","journal-title":"Br J Haematol"},{"key":"2022060701065178000_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/blood-2011-07-370775","article-title":"Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice","volume":"119","author":"Salvestrini","year":"2012","journal-title":"Blood"},{"key":"2022060701065178000_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/0008-5472.CAN-16-1645","article-title":"Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells","volume":"77","author":"Tabe","year":"2017","journal-title":"Cancer Res"},{"key":"2022060701065178000_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2022060701065178000_bib25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.leukres.2005.02.015","article-title":"Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients","volume":"29","author":"Perea","year":"2005","journal-title":"Leuk Res"},{"key":"2022060701065178000_bib26","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1096\/fj.06-7947com","article-title":"Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury","volume":"21","author":"Grenz","year":"2007","journal-title":"FASEB J"},{"key":"2022060701065178000_bib27","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/nmo.12836","article-title":"A commonly used ecto-ATPase inhibitor, ARL-67156, blocks degradation of ADP more than the degradation of ATP in murine colon","volume":"28","author":"Durnin","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"2022060701065178000_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjp.0707361","article-title":"Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases","volume":"152","author":"L\u00e9vesque","year":"2007","journal-title":"Br J Pharmacol"},{"key":"2022060701065178000_bib29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"Skrti\u0107","year":"2011","journal-title":"Cancer Cell"},{"key":"2022060701065178000_bib30","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","article-title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","volume":"125","author":"Sriskanthadevan","year":"2015","journal-title":"Blood"},{"key":"2022060701065178000_bib31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2353\/ajpath.2007.070190","article-title":"Disordered purinergic signaling inhibits pathological angiogenesis in cd39\/Entpd1-null mice","volume":"171","author":"Jackson","year":"2007","journal-title":"Am J Pathol"},{"key":"2022060701065178000_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11302-011-9228-9","article-title":"Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer","volume":"7","author":"K\u00fcnzli","year":"2011","journal-title":"Purinergic Signal"},{"key":"2022060701065178000_bib33","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.leu.2402608","article-title":"Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins","volume":"16","author":"Konopleva","year":"2002","journal-title":"Leukemia"},{"key":"2022060701065178000_bib34","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2011-11-393934","article-title":"Targeting of mTORC1\/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment","volume":"120","author":"Zeng","year":"2012","journal-title":"Blood"},{"key":"2022060701065178000_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/bjc.1997.6","article-title":"Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors","volume":"75","author":"Dixon","year":"1997","journal-title":"Br J Cancer"},{"key":"2022060701065178000_bib36","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.bjp.0703833","article-title":"Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells","volume":"132","author":"Janssens","year":"2001","journal-title":"Br J Pharmacol"},{"key":"2022060701065178000_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.RES.0000153670.07559.E4","article-title":"ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells","volume":"96","author":"Wang","year":"2005","journal-title":"Circ Res"},{"key":"2022060701065178000_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2004.11.027","article-title":"P2Y purinergic receptors regulate the growth of human melanomas","volume":"224","author":"White","year":"2005","journal-title":"Cancer Lett"},{"key":"2022060701065178000_bib39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11302-014-9411-x","article-title":"Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells","volume":"10","author":"Takai","year":"2014","journal-title":"Purinergic Signal"},{"key":"2022060701065178000_bib40","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/bjc.2011.134","article-title":"A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling","volume":"104","author":"Yokdang","year":"2011","journal-title":"Br J Cancer"},{"key":"2022060701065178000_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","article-title":"Purinergic signalling and cancer","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal"},{"key":"2022060701065178000_bib42","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.bbagen.2012.08.013","article-title":"Extracellular ATP induces cell death in human intestinal epithelial cells","volume":"1820","author":"Souza","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2022060701065178000_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1442-2042.2008.02207.x","article-title":"Purinergic receptor-mediated effects of adenosine 5\u2032-triphosphate in urological malignant diseases","volume":"16","author":"Shabbir","year":"2009","journal-title":"Int J Urol"},{"key":"2022060701065178000_bib44","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood-2009-01-202606","article-title":"The leukemic stem cell niche: current concepts and therapeutic opportunities","volume":"114","author":"Lane","year":"2009","journal-title":"Blood"},{"key":"2022060701065178000_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/2040620715619307","article-title":"Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence","volume":"7","author":"Rashidi","year":"2016","journal-title":"Ther Adv Hematol"},{"key":"2022060701065178000_bib46","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1182\/blood-2015-08-665125","article-title":"Targeting leukemia's \u201cfatty tooth.\u201d","volume":"126","author":"Samudio","year":"2015","journal-title":"Blood"},{"key":"2022060701065178000_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2015-07-655860","article-title":"Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy","volume":"128","author":"Moschoi","year":"2016","journal-title":"Blood"},{"key":"2022060701065178000_bib48","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood-2017-03-772939","article-title":"NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts","volume":"130","author":"Marlein","year":"2017","journal-title":"Blood"},{"key":"2022060701065178000_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"2022060701065178000_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4781(02)00343-3","article-title":"Nuclear activators and coactivators in mammalian mitochondrial biogenesis","volume":"1576","author":"Scarpulla","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"2022060701065178000_bib51","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbamcr.2013.12.017","article-title":"Regulation of the biogenesis of OXPHOS complexes in cell transition from replicating to quiescent state: involvement of PKA and effect of hydroxytyrosol","volume":"1843","author":"Signorile","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2022060701065178000_bib52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bbrc.2016.01.089","article-title":"Carvedilol promotes mitochondrial biogenesis by regulating the PGC-1\/TFAM pathway in human umbilical vein endothelial cells (HUVECs)","volume":"470","author":"Yao","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"2022060701065178000_bib53","doi-asserted-by":"crossref","first-page":"33960","DOI":"10.18632\/oncotarget.8986","article-title":"Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia","volume":"7","author":"Perez","year":"2016","journal-title":"Oncotarget"},{"key":"2022060701065178000_bib54","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1038\/cddis.2013.39","article-title":"Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis","volume":"4","author":"Gausdal","year":"2013","journal-title":"Cell Death Dis"},{"key":"2022060701065178000_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2014.04.040","article-title":"cAMP protects acute promyelocytic leukemia cells from arsenic trioxide-induced caspase-3 activation and apoptosis","volume":"736","author":"Safa","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"2022060701065178000_bib56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbrc.2017.05.041","article-title":"Shaping mitochondrial dynamics: the role of cAMP signalling","volume":"500","author":"Di Benedetto","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2022060701065178000_bib57","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1007\/s00018-016-2282-2","article-title":"Mitochondrial cAMP signaling","volume":"73","author":"Zhang","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"2022060701065178000_bib58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.molcel.2019.03.031","article-title":"ER and nutrient stress promote assembly of respiratory chain supercomplexes through the PERK-eIF2\u03b1 axis","volume":"74","author":"Balsa","year":"2019","journal-title":"Mol Cell"},{"key":"2022060701065178000_bib59","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.freeradbiomed.2010.04.031","article-title":"The purinergic P2Y(13) receptor activates the Nrf2\/HO-1 axis and protects against oxidative stress-induced neuronal death","volume":"49","author":"Espada","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"2022060701065178000_bib60","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.bbamcr.2014.05.004","article-title":"Neuroprotection elicited by P2Y13 receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery","volume":"1843","author":"Morente","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2022060701065178000_bib61","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1038\/bcj.2016.36","article-title":"Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets","volume":"6","author":"Maiga","year":"2016","journal-title":"Blood Cancer J"},{"key":"2022060701065178000_bib62","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/2159-8290.CD-14-0341","article-title":"Targeting cancer-derived adenosine: new therapeutic approaches","volume":"4","author":"Young","year":"2014","journal-title":"Cancer Discov"},{"key":"2022060701065178000_bib63","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1158\/2159-8290.CD-19-0541","article-title":"Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity","volume":"9","author":"Li","year":"2019","journal-title":"Cancer Discov"},{"key":"2022060701065178000_bib64","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/leu.2009.143","article-title":"A robust xenotransplantation model for acute myeloid leukemia","volume":"23","author":"Sanchez","year":"2009","journal-title":"Leukemia"},{"key":"2022060701065178000_bib65","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1038\/bcj.2015.19","article-title":"A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia","volume":"5","author":"Saland","year":"2015","journal-title":"Blood Cancer J"},{"key":"2022060701065178000_bib66","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI41495","article-title":"Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD\/SCID\/IL2R\u03b3c-deficient mice","volume":"121","author":"Sarry","year":"2011","journal-title":"J Clin Invest"},{"key":"2022060701065178000_bib67","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ab.2004.09.001","article-title":"Quantitative analysis of the microbial metabolome by isotope dilution mass spectrometry using uniformly 13C-labeled cell extracts as internal standards","volume":"336","author":"Wu","year":"2005","journal-title":"Anal Biochem"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/10\/10\/1544\/1795035\/1544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/10\/10\/1544\/1795035\/1544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T21:07:49Z","timestamp":1654549669000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/10\/10\/1544\/6406\/Extracellular-ATP-and-CD39-Activate-cAMP-Mediated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":67,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-19-1008","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/806992","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.22536355","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536352","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536349.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536352.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536349","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536355.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536358.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536358","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}